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Abstract
Background
We evaluated exercise-induced changes in the profile of circulating cytokines and growth
factors in patients with AS.
Methods
We studied 32 consecutive asymptomatic moderate-to-severe AS patients and 32 age and
sex-matched controls. Plasma levels of interleukin (IL)-6, IL-10, hepatocyte growth factor
(HGF), vascular endothelial growth factor (VEGF), and transforming growth factor (TGF)-β
were measured at 4 time points, i.e. at rest, at peak bicycle exercise, one hour and 24 hours
after a symptom-limited exercise.
Results
Exercise increased all the 5 markers in both groups (all p<0.0001). The maximum levels of
all tested cytokines were higher in the AS group (all p<0.05) compared with controls. In AS
patients the highest levels of VEGF, IL-6, and IL-10 were observed one hour after exercise,
while in the control group at peak exercise. In both groups maximum TGF- β levels were
observed one hour after exercise. HGF levels were higher at peak and one hour after test in
the AS group (p = 0.0001), however the maximum value in AS was observed at peak while
in controls after test. In both groups TGF-βwas the only marker that remained increased 24
hours after exercise compared with the value at rest (p = 0.0001). The cytokines and growth
factors showed no association with heart rate and the workload.
Conclusion
In asymptomatic patients with moderate-to-severe AS, exercise produces a different pattern
of changes in circulating cytokines and growth factors, and maximum levels of all tested
cytokines were significantly higher in AS patients compared with the control group.
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Introduction
Aortic valve stenosis (AS), the most common valvular heart disease in adults, is an active pro-
cess with accumulation of lipids and inflammatory cells, extracellular matrix remodeling,
angiogenesis and calcium deposition, which is to some extent similar to atherosclerosis [1].
AS is characterized by an abnormal mineralization linked with inflammation and neovascu-
larization [2,3]. A combination of endothelial damage and lipid deposition triggers inflamma-
tion within the valve. The infiltration of the endothelial layer predominantly composed of
macrophages and lymphocytes that release pro-inflammatory cytokines stimulate and establish
fibrotic and calcific processes that drive increasing valve stiffness [4]. Inflammatory cells pro-
duce several cytokines that can promote the activation and differentiation of vascular intersti-
tial cells (VICs) [5,6]. Previous studies demonstrated the increased expression of cytokines
including interleukin (IL)-1, IL-6, and transforming growth factor (TGF)-β in calcified human
aortic valves [7]. Recently, El Hussseini et al. have shown that IL-6 is an important mediator of
mineralization and is secreted by VICs in response to phosphate [8]. It has been demonstrated
that TGF-β is expressed within calcific aortic cusps, induces calcification and collagen synthe-
sis in cultured valvular VICs [9,10]. Stenotic aortic valves are vascularized and it contributes
the progression of disease by facilitating the entry of inflammatory cells into the leaflets [2, 11–
14]. Other growth factors like vascular endothelial growth factor (VEGF)-C and VEGF-D
which promote angiogenesis are locally produced by endothelial cells and myofibroblasts of
aortic valve leaflets [15]. Hepatocyte growth factor (HGF), a mesenchymal derived factor, has
been regarded as a intermediator of epithelial-mesenchymal interplays and a powerful inducer
of angiogenesis [16,17]. Recent studies have suggested that HGF had a marked effect on the tis-
sue repair by suppression of proinflammatory cytokine production [17,18]. Endothelium is
extremely sensitive to changes in the blood flow, so turbulence at the supravalvular region in
AS, that increases during exercise, can cause endothelial cell injury followed by a local inflam-
mation. On the other hand, it is known that exercise protects against disease associates with
chronic low-grade systemic inflammation [19]. Beneficial effects of physical activity in terms
of lower risk of coronary artery disease (CAD) and cardiovascular mortality may result at least
in part from modulation of inflammation following exercise. Konstantinos et al. demonstrated
that exercise performed in CAD patients is safe without exacerbating underlying inflamma-
tion. They observed that exercise elicited normal pro-and anti-inflammatory responses, ana-
lyzing concentrations of tumor necrosis factor (TNF)-α, high sensitivity C-reactive protein
(hs-CRP), interferon (INF)-γ, IL-6, IL-10 and TGF-β [20].
To our knowledge, there have been no studies investigating the effect of exercise on circu-
lating concentrations of cytokines and growth factors in AS patients as compared to well-
matched controls. We hypothesized that exercise-induced hemodynamic changes unfavorably
alter the profile of circulating cytokines and growth factors in AS patients as compared to well
matched healthy controls.
Materials and methods
Study design
We enrolled 33 patients (16 males and 17 females) with asymptomatic moderate-to-severe AS
defined as transvalvular maximal velocity [Vmax]3 m/s [21]. Sex- and age-matched individu-
als recruited from the hospital staff and relatives served as controls. The two groups have been
described in detail previously [22]. Briefly, the exclusion criteria were: history of angina, myo-
cardial infarction, stroke, dizziness, or syncope, another cardiac valve disease of more than a
moderate degree, left ventricular (LV) ejection fraction (EF) <50%, prior or current atrial
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fibrillation, hyper- or hypothyroidism, diabetes treated with insulin, renal or liver dysfunction,
chronic pulmonary disease, treatment with oral anticoagulants, thienopyridine or nonsteroidal
anti-inflammatory drugs other than aspirin, known cancer, autoimmune disorders, inability
to perform exercise testing. The study protocol was approved by the Bioethics Committee of
the District Medical Chamber, and each patient provided written, informed consent to partici-
pate in the study.
To evaluate the extent of atherosclerotic vascular disease, which coexists in about 50% of AS
patients [23], we measured intima-media thickness (IMT) in both right and left common
carotid artery in accordance with the Mannheim IMT consensus [24]. Ankle Brachial Pressure
Index (ABI) was measured using an arterial pressure sphygmomanometer and a continuous
wave Doppler ultrasound blood flow detector and the ABI values of 0.9–1.15 were considered
normal. Hypertension was diagnosed based on a history of arterial hypertension or antihyper-
tensive treatment. Hyperlipidaemia was diagnosed based on medical records, statin therapy or
total cholesterol of5.0 mmol/L.
Echocardiography
Transthoracic echocardiography was performed in all subjects using Philips iE33 device.
LV volumes and EF were measured by the biplane Simpson’s method. The aortic valve area
(AVA) was calculated using the standard continuity equation. Vmax, peak pressure gradient
(PPG) and mean pressure gradient (MPG) were calculated using the modified Bernoulli
equation.
A symptom-limited exercise stress echocardiography was performed on a bicycle ergometer
(Ergoline) in a semi supine position with a continuous echocardiographic examination by an
experienced cardiologist. After 3 minutes of the initial workload of 25W, the workload was
increased every 3 minutes by 25W. ECG was monitored and blood pressure was measured
every 3 minutes during exercise. Exercise was stopped in case of typical chest pain, breathless-
ness, dizziness, muscular exhaustion, hypotension, ventricular arrhythmia, when age-related
maximum heart rate was reached or on patient’s demand. The test was performed at rest and
at peak exercise.
Laboratory tests
Fasting blood samples were drawn from the antecubital vein between 7 and 10 a.m. Fibrinogen
was measured by the von Clauss method. High-sensitivity C-reactive protein was determined
using immunoturbidimetry (Roche Diagnostics, Mannheim, Germany). Blood samples were
drawn four times: at rest, at peak exercise, one hour and 24 hours after exercise. Blood was cen-
trifuged at 2500 g at 20˚C for 10 min and stored at -80˚C until analysis. Technicians were
blinded to the origin of the samples.
Plasma levels of the following biomarkers: IL-6 and IL-10, HGF, VEGF, and TGF-β were
measured with the use of commercially available enzyme-linked immunosorbent assays
(ELISA; R&D Systems, Abington, UK) according to the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using STATISTICA 10 PL software package. Values are pre-
sented as a mean± standard deviation or median or otherwise stated. The Shapiro-Wilk test
was performed to determine normal distribution of the variables. The Student’s t test was used
to determine differences among normally distributed variables and the Mann–Whitney U test
for non-normally distributed variables. Serial tests were analyzed using Friedman ranks
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analysis of variance. A linear Pearson correlation was used to assess correlations among vari-
ables. A two-sided p-value<0.05 was considered statistically significant.
Results
Thirty-two AS patients (MPG of 35.4±14.1 mmHg, AVA = 1.08±0.23 cm2;) and 32 controls
were included in the final analysis (Table 1).
The duration of stress test was shorter in AS group (9.0±1.9 min vs 10.8±2.7 min; p = 0.008)
and maximum workload was lower (81.3±21.1 W; p = 0.002). Echocardiographic data are pre-
sented in Table 2.
Interleukin-6
The baseline IL-6 concentrations were similar in the AS and control groups (Fig 1 and
Table 2). In response to exercise IL-6 levels increased (+325%) with the highest levels one hour
after exercise in AS patients, while IL-6 rose similarly to maximum value at peak exercise
(+231%) in the control group (Table 2). In the AS group we found positive correlations
between baseline IL-6 and BMI (r = 0.693, p = 0001). The level of IL-6 measured 1h post exer-
cise correlated with total cholesterol (r = 0.378, p = 0.033) and LDL cholesterol (r = 0.366,
p = 0.040). The level of IL-6 measured 24 h post exercise correlated with age (r = 0.518,
p = 0.02) and with hs-CRP (r = 0.343, p = 0.054).
Interleukin-10
IL-10 was similar at baseline and at peak exercise in both groups, but one hour after exercise it
was higher (+141%) in AS group and (+61.8%) in the control group (Table 2, Fig 2).
TGF-β
As shown in Fig 3 and Table 2, the levels of TGF-β were higher among AS patients than in the
control group both at baseline, peak exercise, one and 24 hours after exercise (all p<0.005). In
AS group TGF-β was increased during the test with the highest levels one hour after exercise
(+77.7%). In the control group the highest TGF-β levels were observed at peak exercise
(+60.4%). In AS patients TGF-β detected at baseline and 24 h post exercise correlated with hs-
CRP (r = 0.44, p = 0.011; r = 0.561, p = 0.01, respectively), but not with fibrinogen or
demographics.
HGF
In response to exercise HGF levels increased in both groups with the highest levels at peak
exercise. In AS patients the levels of HGF were higher in all time points compared with the
controls (+21%), (all p< 0.005) (Fig 4, Table 2). In AS group age correlated with HGF at base-
line (r = 0.351, p = 0.049), 1 h (r = 0.361, p = 0.042) and 24h post exercise (r = 0.469,
p = 0.007). HGF showed no association with inflammatory markers or lipid variables (data not
shown).
VEGF
The baseline level of VEGF was similar between AS patients and the control group. Exercise
induce the highest level of VEGF was observed one hour after exercise in AS (+100%) and was
higher compared with the controls (+54.1%) (Fig 5). In AS group baseline VEGF and 24h post
exercise test levels correlated with BMI (r = 0.802, p = 0.001; r = 0.684, p = 0.001, respectively).
Post-exercise changes in cytokines and growth factors in aortic valve stenosis
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Associations with echocardiographic variables. In both groups we did not observe any
associations of the biomarkers tested with heart rate, the workload calculated in Watts. Of the
studied parameters describing the severity of AS, we found the only positive correlation
between AVA and IL-6 levels at rest (r = 0.426, p = 0.015).
Discussion
The current study is the first to demonstrate that exercise modulates the release of cytokines
and growth factors in asymptomatic patients with moderate-to-severe AS and the profile of
exercise-induced changes significantly differs in AS from that observed in well-matched con-
trols. The same cohort was also investigated how stress echocardiography alters blood coagula-
tion and fibrinolysis, as described in detail previously [22]. At rest AS patients had higher HGF
and TGF-β but not IL-6, IL-10 and VEGF levels. Our study showed that the post-exercise
increases in plasma concentrations of IL-6, IL-10, TGF-β, HGF and VEGF were more pro-
nounced and maximum levels of all tested cytokines were significantly higher in AS patients
compared with the controls. Interestingly, the peak value of Il-6, IL-10, TGF-β and VEGF was
observed one hour post-exercise. This study increases our knowledge on a complex role of
exercise in modulation of cytokine balance and indicates that hemodynamically significant
heart valve defects may alter the profile of circulating cytokines and growth factors with the
largest impact on IL-6.
Table 1. Baseline characteristics.
Variables AS patients (n = 32) Controls (n = 32) p
Males, n (%) 15 (46.8) 17 (53.1) 0.62
Age (years) 64 (23–82) 63.5 (33–83) 0.81
BMI (kg/m2) 30 (21–37) 28 (21–39) 0.19
Current Smoking, n (%) 2 (6.2) 2 (6.2) 1.0
Hypertension, n (%) 26 (81.2) 27 (84.3) 0.74
Diabetes, n (%) 7 (21.8) 4 (12.5) 0.32
Hypercholesterolaemia, n (%) 12 (37.5) 2 (6.2) 0.02
Laboratory investigations
Fibrinogen (g/L) 3.26 ± 0.7 3.04 ± 0.5 0.21
Total cholesterol (mM) 5.03 ± 1.04 5.26 ± 1.2 0.41
LDL cholesterol (mM) 3.04 ± 0.8 3.33 ± 1.0 0.24
HDL cholesterol (mM) 1.48 ± 0.3 1.48 ± 0.4 0.92
Triglycerides (mM) 1.15 (0.4–4.2) 1.15 (0.4–2.3) 0.50
Glucose (mM) 5.85 ± 1.1 5.38 ± 0.5 0.30
Creatinine (μM) 73.8 ± 12.4 77.3 ± 13.9 0.28
C-reactive protein (mg/L) 1.23 (0.3–10.4) 1.6 (0.2–8.0) 0.61
Treatment
Aspirin, n (%) 18 (56.2) 10 (31.2) 0.044
Statins, n (%) 23 (71.8) 20 (62.5) 0.42
β-blockers, n (%) 19 (59.3) 12 (37.5) 0.08
ACEI, n (%) 12 (37.5) 15 (46.8) 0.45
Data are median (interquartile range) or mean ± SD, unless otherwise stated. P value was measured using Student t-test when variables were normally
distributed or by the Mann-Whitney U-test for non-normally distributed variables. Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; HDL,
high-density lipoprotein; ACEI, angiotensin-converting enzyme inhibitor
https://doi.org/10.1371/journal.pone.0173787.t001
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IL-6
It is known that IL-6 is abundantly released into the circulation during exercise [19].
It has been reported that in healthy, young volunteers IL-6 levels were significantly elevated
immediately post-exercise [25]. The gene expression of IL-6 in skeletal muscle increases fol-
lowing exercise [26] and the main source of the release of IL-6 were skeletal muscle [27]. Adi-
pose tissue and peripheral blood mononuclear cells may also contribute to IL-6 in the
circulation at rest [28]. Data on post-exercise changes of IL-6 levels in atherosclerosis related
diseases are equivocal. In patients with chronic heart failure, a nonsignificant increase of IL-6
following exercise has been shown [29]. Volaklis et al. observed an increase in IL-6 levels
immediately after exercise in middle-aged patients with CAD [30]. Previous studies demon-
strated elevated IL-6 levels in AS patients [31]. Expression of IL-6 on stenotic aortic valve leaf-
lets was also observed [7,8]. We provided evidence that in AS group, IL-6 levels markedly
Table 2. Clinical, exercise and echocardiographic data.
Variables AS (n = 32) K (n = 32) p
Clinical and Exercise Data
Resting
Heart rate (bpm) 65.3 ± 10.1 68.1 ± 10.9 0.423
Systolic arterial pressure (mm Hg) 131.9 ± 10.1 133.6 ± 11.9 0.870
Diastolic arterial pressure (mm Hg) 76.8 ± 8.8 78.6 ± 6.9 0.549
Maximal workload (WATT) 81.3 ± 21.1 100.8 ± 22.4 0.002
Duration (min) 9.0 ± 1.9 10.8 ± 2.7 0.008
Exercise
Heart rate (bpm) 113.3 ± 21.9 122.7 ± 17.4 0.043
Systolic arterial pressure (mm Hg) 158.4 ± 10.2 166.5 ± 18.3 0.108
Diastolic arterial pressure (mm Hg) 83.1 ± 5.6 84.9 ± 9.1 0.257
Resting and Exercise Echocardiographic Data
Resting
LVEF (%) 66.3 ± 7.3 69.8 ± 7.6 0.079
LVEDV (ml) 96.4 ± 27.7 92.7 ± 28.3 0.519
LVEDV/BSA (ml/m2) 51.9 ± 13.4 49.2 ± 13.7 0.376
LV mass (g) 208.8 ± 59.6 150.7 ± 43.1 <0.001
LV mass BSA (g/m2) 109.5 ± 24.0 78.4 ± 20.1 <0.001
LA area (cm2) 20.3 ± 4.7 15.5 ± 2.9 <0.001
LA volume (ml) 58.5 ± 23.1 40.5 ± 11.5 <0.001
LA volume//BSA (ml/m2) 29.9 (17.6–65) 22.5 (8.3–35) <0.001
Ascending aorta (mm) 38.7 ± 5.7 32.8 ± 3.9 <0.001
PPG (mmHg) 59.4 ± 19.8 8.0 ± 3.6 <0.001
MPG (mmHg) 35.4 ± 14.1 4.4 ± 1.8 <0.001
AVA (cm2) 1.0 ± 0.23
AVA/BSA (cm2/m2) 0.58 ± 0.11
Exercise
PPG (mmHg) 75.3 ± 26.1
MPG (mmHg) 45.3 ± 15.9
AVA (cm2) 1.1 ± 0.3
AVA/BSA (cm2/m2) 0.58 ± 0.14
Abbreviations: LVEF- left ventricular ejection fraction; LVEDV- left ventricular end diastolic volume; BSA- body surface area; LV- left ventricle; LA- left
atrium; PPG- peak pressure gradient; MPG- mean pressure gradient; AVA- aortic valve area
https://doi.org/10.1371/journal.pone.0173787.t002
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increased during exercise and the maximum levels were significantly higher as compared to
the control. It can be concluded that AS patients have increased pro-inflammatory burden
compared to the healthy population and they have stronger response to the exercise challenge.
A positive correlation of exercise-induced increase in IL-6 with AVA in the present study sug-
gests a close link between the severity of the disease and IL-6-mediated inflammatory state.
IL-10
IL-10 is a cytokine with pleiotropic effects affecting immunoregulation and inflammation.
Recently it has been reported that genetic polymorphism of IL-10 may be associated with the
susceptibility to valvular calcification [32].
The studies carried out in healthy young volunteers indicate that there is a dissociation
between exercise-induced local gene expression in skeletal muscle and systemic concentration
of IL-10 [26]. Conversely, the circulating concentration of IL-10 increases markedly, but this
cytokine is not expressed in skeletal muscle after exercise [26].
Fig 1. Exercise-induces changes during symptom-limited exercise on a bicycle ergometer in 32
asymptomatic aortic valve stenosis patients (AS) and 32 well-matched Controls (C) in Interleukin- 6
(IL-6).
https://doi.org/10.1371/journal.pone.0173787.g001
Fig 2. Exercise-induces changes during symptom-limited exercise on a bicycle ergometer in 32
asymptomatic aortic valve stenosis patients (AS) and 32 well-matched Controls (C) in Interleukin- 10
(IL-10).
https://doi.org/10.1371/journal.pone.0173787.g002
Post-exercise changes in cytokines and growth factors in aortic valve stenosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0173787 March 14, 2017 7 / 14
Among patients with AS we observed a significantly higher and prolonged post exercise
increase of IL-10 compared to the control group. Given the stimulating effect of exercise on
the release of pro-inflammatory cytokines including TNF-alpha and the inhibitory effect of IL-
10 on TNF—alpha [33], the increase in serum IL-10 levels in the AS group can be considered a
compensative anti-inflammatory response.
Fig 3. Exercise-induces changes during symptom-limited exercise on a bicycle ergometer in 32
asymptomatic aortic valve stenosis patients (AS) and 32 well-matched Controls (C) in TGF-β
(transforming growth factor).
https://doi.org/10.1371/journal.pone.0173787.g003
Fig 4. Exercise-induces changes during symptom-limited exercise on a bicycle ergometer in 32
asymptomatic aortic valve stenosis patients (AS) and 32 well-matched Controls (C) in HGF
(hepatocyte growth factor).
https://doi.org/10.1371/journal.pone.0173787.g004
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TGF-β
TGF-β is a multifunctional cytokine which has proliferative activity on cardiac and valvular
fibroblasts. TGF-β induces hypertrophy and apoptotic cell death in cardiomyocytes and with
the other cytokines it ultimately stimulates fibrotic and calcific processes that drive valve stiff-
ness [4]. The presence of TGF-β has been reported in stenotic aortic valves [7].
Peake et al. have reported that plasma concentrations of TGF-β remained unchanged fol-
lowing exercise [26]. However, Volaklis et al. observed an increase of TGF-β only in CAD
patients in whom the low intensity protocol was used [30]. We observed increased TGF-β not
only 1 hour after exercise but even 24 hours after exercise in AS patients. Valvular endothelial
cells respond to local shear stress changes to modulate intracellular signaling which leads to
altered gene expression, cell morphology and structural remodeling [34]. Healthy aortic valve
endothelium is resistant to molecular diffusion and cell penetration into the tissue interstitial
space and bloodstream. Leaflets exposed to altered shear stress demonstrate increased expres-
sion of the inflammatory proteins, TGF- β, only on the aortic side that indicates the side-
dependent shear sensitivity [35]. In animal models of AS, it has been demonstrated that there
is a relationship between shear stress and serum TGF-β levels [36]. An exercise by increasing
shear stress [37] and turbulent blood flow in the supravalvular region can activate TGF-β in
the aortic valve endothelial cells [35], which may explain a higher and prolonged post-exercise
increase of serum TGF-β observed in the AS group.
HGF
HGF counteracts the activity of TGF-β. HGF suppresses myocardial hypertrophy and its
down-regulation activity on fibrogenic and hypertrophic genes is associated with improved
cardiac function. HGF enhances endothelial NO production [38]. It was reported that HGF
increase induced by pharmacological stimulation could favorably improve exercise-induced
ischaemia in patients with CAD [39]. Wahl et al. demonstrated post-exercise increase in HGF
(3 hours after) in young, healthy non-smoking males [16]. We observed higher levels of HGF
both at baseline and post exercise in the AS group. It might be speculated that in AS, the post-
exercise HGF release is protective by inhibition of apoptosis and enhancement of valvular
endothelium repair.
Fig 5. Exercise-induces changes during symptom-limited exercise on a bicycle ergometer in 32
asymptomatic aortic valve stenosis patients (AS) and 32 well-matched Controls (C) in VEGF (vascular
endothelial growth factor).
https://doi.org/10.1371/journal.pone.0173787.g005
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VEGF
VEGF has been demonstrated in stenotic aortic valves, precisely [15,40]. VEGF act predomi-
nantly on vascular endothelial cells by stimulating neoangiogenesis and facilitating the entry of
inflammatory cells and lipids into the leaflets, thus accelerating progression of AS [14].
Increased plasma VEGF in aged patients associates with AS [41]. Wahl et al. demonstrated an
immediate post-exercise increase in VEGF levels in young, healthy non-smoking males [16].
Kraus et al. also observed an increase in VEGF immediately after and 2 hours after exercise in
well-trained athletes [42]. Our findings showed that in AS the maximum levels of VEGF were
markedly higher compared with the controls and was observed one hour after exercise. Based
on our findings, it might be hypothesized that the post-exercise increase in angiogenic factors
(VEGF and TGF-β) in the AS group may affect remodeling of the stenotic aortic valve.
The relationship between exercise and cytokine release
Previous observations indicate that not all of cytokines expressed in skeletal muscles are
released during post- exercise period into the circulation [26].
Importantly the duration of bicycle exercise was shorter and maximum workload was lower
in the AS group compared to the control but the maximum levels of cytokines were higher,
which further suggest other than muscle source of its release.
In our opinion the cytokine release in AS was induced by exercise and this effect was
enhanced by chronic low-grade inflammation, therefore differed markedly from controls.
It is likely that the release of cytokines beyond the known source of the muscle occurs
locally in the supravalvular region. Turbulence at supravalvular region in AS patients, that
increases during exercise, can damage the endothelium followed by a local pro-inflammatory
state. It is known that exercise protects against diseases associated with chronic low-grade sys-
temic inflammation [24], however it is unclear whether post-exercise increase of cytokines
observed in AS is protective. Exercise-induced increases in blood flow and shear stress have
been observed to enhance vascular function and structure. Where there is a laminar flow, the
adhesion of inflammatory molecules and activation of pro-inflammatory cascade are reduced.
By increasing the release of nitric oxide and prostacyclin, shear stress augments endothelium-
dependent vasodilatation and inhibits multiple processes involved in atherogenesis [43].
In AS the blood flow in the supravalvular region is turbulent compounded by the effort.
It is unknown whether exertional increased activity of cytokines may slow down the inflam-
matory process ongoing on the valve and inhibit its remodeling or whether it is only an indica-
tor of hemodynamic disruption. It is still controversial whether inflammatory mediators have
primarily causal or counter-regulatory functions [44]. On the other hand, since activated cyto-
kines can be a stimulus and result of valvular calcification alike (vicious cycle by which inflam-
mation promotes VICs and VICs itself promotes inflammation) [45,46]. Kastellanos et al. have
clearly showed that the decrease in the levels of inflammatory cytokines after aortic valve
replacement, however before aortic valve replacement there was no relation between inflam-
matory markers and echocardiographic parameters [47]. We suggest that the exercise-stimu-
lated increase of pro-inflammatory cytokines is undesirable.
Study limitations
Both study groups were small, however their size was sufficient to show the intergroup differ-
ences in measured parameters. We measured only serum levels of cytokines, gene expression
was not identified. Our findings cannot be likely extrapolated to the whole population of AS
patients since the study participants with mild or symptomatic AS were excluded.
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Conclusion
Our study demonstrated that in asymptomatic patients with moderate-to-severe AS, exercise
stimulate a higher increase in pro-inflammatory cytokines than that in the control group, sug-
gesting enhanced post-exercise inflammatory state in AS.
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15. Syväranta S, Helske S, Lappalainen J, Kupari M, Kovanen PT. Lymphangiogenesis in aortic valve ste-
nosis—novel regulatory roles for valvular myofibroblasts and mast cells. Atherosclerosis 2012;
221:366–74. https://doi.org/10.1016/j.atherosclerosis.2011.12.034 PMID: 22281299
16. Wahl P, Jansen F, Achtzehn S, Schmitz T, Bloch W, Mester J et al. Effects of high intensity training and
high volume training on endothelial microparticles and angiogenic growth factors. PLoS One 2014; 9:
e96024. https://doi.org/10.1371/journal.pone.0096024 PMID: 24770423
17. Konya H, Miuchi M, Satani K, Matsutani S, Tsunoda T, Yano Y et al. Hepatocyte growth factor, a bio-
marker of macroangiopathy in diabetes mellitus. World J Diabetes 2014; 15;5:678–88.
18. Wang N, Tong G, Yang J, Zhou Z, Pan H, Huo Y et al. Effect of hepatocyte growth-promoting factors on
myocardial ischemia during exercise in patients with severe coronary artery disease. Int Heart J 2009;
50:291–9. PMID: 19506333
19. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154–
1162. https://doi.org/10.1152/japplphysiol.00164.2004 PMID: 15772055
20. Konstantinos AV, Smilios I, Spassis AT, Zois CE, Douda HT, Halle M et al. Acute pro- and anti-inflam-
matory responses to resistance exercise in patients with coronary artery disease: a pilot study. J Sports
Sci Med 2015; 14:91–97. PMID: 25729295
21. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guide-
lines for the management of patients with valvular heart disease: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise
the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collab-
oration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascu-
lar Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114:e84–
231. https://doi.org/10.1161/CIRCULATIONAHA.106.176857 PMID: 16880336
22. Kolasa-Trela R, Fil K, Wypasek E, Undas A. Exercise stress testing enhances blood coagulation and
impairs fibrinolysis in asymptomatic aortic valve stenosis. J Cardiol 2015; 65:501–7. https://doi.org/10.
1016/j.jjcc.2014.07.019 PMID: 25169013
23. Kobayashi J. Changing strategy for aortic stenosis with coronary artery disease by transcatheter aortic
valve implantation. Gen Thorac Cardiovasc Surg 2013; 61:663–8. https://doi.org/10.1007/s11748-013-
0242-4 PMID: 23546769
Post-exercise changes in cytokines and growth factors in aortic valve stenosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0173787 March 14, 2017 12 / 14
24. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al. Mannheim carotid
intima-media thickness and plaque consenus (2004-2006-2011). An update on behalf of the advisory
board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke
Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011.
Cerebrovasc Dis 2012; 34:290–296. https://doi.org/10.1159/000343145 PMID: 23128470
25. Sim M, Dawson B, Landers G, Swinkels DW, Tjalsma H, Trinder D et al. Effect of exercise modality and
intensity on post-exercise interleukin-6 and hepcidin levels. Int J Sport Nutr Exerc Metab 2013; 23:178–
186. PMID: 23070801
26. Peake JM, Della Gatta P, Suzuki K, Nieman DC. Cytokine expression and secretion by skeletal muscle
cells: regulatory mechanisms and exercise effects. Exerc Immunol Rev 2015; 21: 8–25. PMID:
25826432
27. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B. Production of interleu-
kin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma
interleukin-6. J Physiol 2000; 529:237–42. https://doi.org/10.1111/j.1469-7793.2000.00237.x PMID:
11080265
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